• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar
  • Skip to footer
  • Quixnet Email
  • My Account
  • Quixnet Downloads
  • Dial up locations
  • User Agreement

Welcome to Quixnet

  • Breaking News
  • World
  • US
  • Business
  • Sports
  • Technology

Merck shares surge anew on lung cancer advance, while Bristol-Myers stock plummets

April 15, 2018 by quixnet

  1. Merck shares surge anew on lung cancer advance, while Bristol-Myers stock plummetsMarketWatch
  2. Survival data boosts Merck’s Keytruda lead in lung cancerReuters
  3. Bristol-Myers has Farther to FallWall Street Journal
  4. I/O combos inch forward in pharma’s lung cancer questBioPharma Dive
  5. Merck Tightens Its Grip on the Lung-Cancer MarketBloomberg
  6. Full coverage

Filed Under: Business

Primary Sidebar

Quote of the Day

Life doesn't imitate art, it imitates bad television.
Woody Allen

this day in history


Footer

Read More

  • Breaking News
  • World
  • US
  • Business
  • Sports
  • Technology

My Account & Help

  • Quixnet Email
  • My Account
  • Quixnet Downloads
  • Dial up locations
  • User Agreement

Contact

  • Billing: 1-855-324-8915
  • Support: 1-877-225-1996
  • support@quixnet.net

© 2018 · Urban Communications Inc.